Coronavirus: Sinopharm applies for regulatory approval from China to launch vaccine, state media reports

A front runner among China’s coronavirus vaccine developers has filed for approval to officially launch its product, after rival vaccines in the United States and Britain got a head start in proving the high efficacy of their candidates.China National Pharmaceutical Group, known as Sinopharm and whose subsidiary company China National Biotec Group is developing two inactivated coronavirus vaccines, has filed for regulatory approve to launch the vaccines, Xinhua Finance reported on Tuesday,…

Read the original article at South China Morning Post